A research partnership with the Parkinson’s Foundation helped Pfizer Inc. streamline a clinical program in Parkinson’s disease and identify outcomes to measure that are more in line with patients’ priorities.
As a result of the collaboration, Pfizer reports that study enrollment has been faster than expected.
The Parkinson’s Foundation’s mission includes investing in and advocating for research to end the disease and improve quality of life for patients and their families. To that end, it trains and helps connect patient and caregiver advocates to researchers in academia, government or industry who are seeking patient perspectives on their projects.
“If we added that expertise to that of researchers